FDA Inspection 1310538 - Nostrum Laboratories Inc - April 02, 2026

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Nostrum Laboratories Inc

Record Details

This FDA Inspection record concerns Nostrum Laboratories Inc, with an inspection on April 2, 2026, issued by the Kansas City District Office, covering human drugs.

Company: Nostrum Laboratories Inc
Inspection Date: April 2, 2026
Product Type: Human Drugs
Office: Kansas City District Office

Open in Dashboard

ID · cce12f64-1208-4390-9fc0-0a45e20b08e5

Violation Codes10

21 CFR 211.100(a)21 CFR 211.166(b)21 CFR 211.19221 CFR 211.198(a)21 CFR 211.22(d)21 CFR 211.67(a)21 CFR 211.68(b)21 CFR 211.84(b)FDCA 582(b)(4)FDCA 582(g)(1)

Full citation text and observation details available on the Dashboard.